Drug Name: IPL344
Company: Immunity Pharma
Location: Israel
Website: http://www.immunitypharma.com/
Drug Type: Protein Biologic
Conditions: ALS
Mechanism Type: Neuroprotection
Mechanism: IPL344 is an activator of the Akt pathway, a key signaling pathway in cell survival and repair.In mutant SOD1 mouse models of ALS, IPL344 delayed disease progression and prolonged survival.
U.S. Status for ALS: Preclinical

[1] Immunity Pharma – Pipeline. Immunity Pharma, n.d. Accessed 9 Mar 2016 from http://www.immunitypharma.com/company/.

Last updated March 9th, 2019

Share this: